More GLP-1s and Oral Options Could Shift the Weight Loss Drug Market | Asembia's AXS25 Summit

News
Video

Becky Davis of Charles River Associates predicts that an influx of new and oral GLP-1 drugs, along with pricing pressures from policy and competition, will reshape the weight loss drug market in the next two years.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.